Patient Empowerment Program: A Rare Disease Podcast

De : n-Lorem Foundation (Dr. Stan Crooke Amy Williford Kim Butler Andrew Serrano Jon Magnuson and Kira Dineen)
  • Résumé

  • Join the nano-rare disease community! Interviews features leading physicians, scientists, biotech experts, and patient advocates. Lessons teach core concepts about drugs. Our host Dr. Crooke has led the creation of antisense technology and his foundation, n-Lorem, is using this powerful technology to discover, develop, and provide personalized experimental antisense oligonucleotide medicines to nano-rare patients for free, for life. n-Lorem is a non-profit organization established to apply the efficiency, versatility and specificity of antisense technology to charitably provide experimental antisense oligonucleotide (ASO) medicines to treat patients (less than 30 patients) that are the result of a single genetic defect unique to only one or very few individuals. The advantage of experimental ASO medicines is that they can be developed rapidly, inexpensively and are highly specific. n-Lorem was founded by Dr. Stan Crooke, who founded IONIS Pharmaceuticals in 1989 and, through his vision and leadership, established the company as the leader in RNA-targeted therapeutics. The podcast is produced by n-Lorem Foundation and hosted by Dr. Stanley T. Crroke, who is the Founder, CEO and Chairman. Our videographer is Jon Magnuson. Our producers are Kira Dineen, Jon Magnuson, Kim Butler, and Amy Williford. To learn more about n-Lorem, visit nlorem.org. Contact us at podcast@nlorem.org.
    Copyright 2024 n-Lorem Foundation
    Afficher plus Afficher moins
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • Q&A - 2024 Nano-rare Patient Colloquium Recap
      Dec 18 2024

      Join Stan Crooke, n-Lorem founder, CEO, and host of the Patient Empowerment Program Podcast, alongside Amy Williford, Sr. Director of Communications and Donor Relations, for a special episode.

      In this post-colloquium Q&A, Stan recaps the 2024 Nano-rare Patient Colloquium and the progress n-Lorem has made as the organization nears its 5-year anniversary, shares his candid reflections on the event, and dives into additional thoughts and questions that weren’t covered.

      Do you have additional questions? Email podcast@nlorem.org.

      Question Bank:

      1. 2:15 How do you think the event went this year?
      2. 6:05 Were observations of benefit expected in patients so quickly?
      3. 9:47 What do you expect the number of patients treated to be next year?
      4. 10:57 Do you have a message to supporters?
      5. 12:30 Were there any disappointments from the colloquium?
      6. 13:21 What are the most important things that n-Lorem has learned this year?
      7. 16:13 Do you think n-Lorem’s processes will be outlined every year at the event?
      8. 18:05 How is AI incorporated at n-Lorem?
      9. 19:10 Does your recently announced deal with GondolaBio reflect the sustainability strategy discussed at the event?
      10. 20:53 n-Lorem is celebrating 5 years in 2025. Did you expect the foundation to be where it is today?
      11. 21:28 Does n-Lorem plan to expand into Europe and elsewhere?

      Make hope possible with a donation.

      Afficher plus Afficher moins
      24 min
    • Best of the 2024 Nano-rare Patient Colloquium
      Dec 4 2024

      This year’s Colloquium spanned two perfect autumn days in beautiful Cambridge, Massachusetts where hundreds of nano-rare community members from around the world gathered under a single roof to learn, connect, and support one another. We’re pleased to announce that the event welcomed over 750 attendees, both in-person and virtually. It’s each and every one of you who made the event such a success! For this special episode, we gathered the ‘Best’ clips from the event for you to learn from and enjoy.

      To submit questions for our upcoming Q&A episode, email podcast@nlorem.org. We can’t wait to hear from you! 2024 Colloquium Recap

      On this episode:

      • 2:07 Daphne Graskewicz-Prado, ASO The Perilous Journey to Diagnosis and Treatment for Nano-rare
      • 9:35 Ryan Strankowski and Dr, Nelson Leung, Ryan’s Journey and Clinical Experience
      • 15:55 Luke Rosen, Megan Hedstrom, and Dr. Jennifer Bain, Susannah’s & Sloane’s Journeys and Unique Clinical Experiences
      • 21:49 Kelley Dalby and Dr. Olivia Kim-McManus, Connor’s Journey and Clinical Experience
      • 30:00 Dr. Julie Ziobro and Dr. Horacio Kaufmann, Building a Nano-rare Network and Managing Institutional Challenges
      • 37:38 Dr. Andrew Lo and Dr. Alan Lotvin, Innovative Ways to Support Nano-rare
      • 42:30 Dr. Toby Ferguson, Dr. Liz Berry-Kravis, and Dr. Eugene Shneider, Changing the World One Patient at a Time
      • 47:30 Dr. Kate Dawson, What It Means to be a Parter with n-Lorem for Nano-rare
      • 50:23 Dr. Stanley Crooke, Providing Hope for a Better Future, One Nano-rare Patient at a Time
      Afficher plus Afficher moins
      58 min
    • Susannah's Progress: Two Years of ASO Treatment with Dr. Jennifer Bain and Luke Rosen
      Oct 16 2024

      Two years of treatment—two years of strength, courage, and blazing a trail for other nano-rare patients! 🎉 Susannah's story was the first shared on the Patient Empowerment Program podcast. Now, two years later, her father, Luke Rosen, and her physician, Dr. Jennifer Bain, detail Susannah’s remarkable progress since beginning regular treatments—highlighting improvements in her motor skills, cognition, energy, and more!

      Susannah's Story (May 25, 2022)

      Donate

      2024 Nano-rare Patient Colloquium

      On This Episode We Discuss:

      • 3:10 Susannah's KIF1A mutation
      • 5:50 Luke and his wife Sally changed their careers to help find a treatment for KIF1A
      • 7:23 How Susannah's family first heard of n-Lorem
      • 8:43 Jen on the Columbia University Medical Center team and the decision to treat Susannah
      • 12:25 Luke's experience bringing his daughter to receive an experimental ASO treatment for the first time
      • 14:30 The positive outcomes and observations of Susannah's treatment
      • 26:15 What Dr. Bain has learned since treating Susannah
      • 29:15 Luke on the impact and importance of the little things
      • 31:15 Advice to other parents
      • 35:40 Being part of a community of nano-rare patients and families
      Afficher plus Afficher moins
      41 min

    Ce que les auditeurs disent de Patient Empowerment Program: A Rare Disease Podcast

    Moyenne des évaluations utilisateurs. Seuls les utilisateurs ayant écouté le titre peuvent laisser une évaluation.

    Commentaires - Veuillez sélectionner les onglets ci-dessous pour changer la provenance des commentaires.

    Il n'y a pas encore de critique disponible pour ce titre.